[2-[ACETYL-(BETA-D-GALACTOPYRANOSYL)-AMINO]-2-PHENYLACETYLAMINO]-ACETIC-ACID-METHYLESTER
Compound with spectra: 1 NMR
![[2-[ACETYL-(BETA-D-GALACTOPYRANOSYL)-AMINO]-2-PHENYLACETYLAMINO]-ACETIC-ACID-METHYLESTER](/api/compound/A2SwzzLDFsa.png?ph=true&h=300&w=458 "[2-[ACETYL-(BETA-D-GALACTOPYRANOSYL)-AMINO]-2-PHENYLACETYLAMINO]-ACETIC-ACID-METHYLESTER")
| SpectraBase Compound ID | A2SwzzLDFsa |
|---|---|
| InChI | InChI=1S/C19H26N2O9/c1-10(23)21(19-17(27)16(26)15(25)12(9-22)30-19)14(11-6-4-3-5-7-11)18(28)20-8-13(24)29-2/h3-7,12,14-17,19,22,25-27H,8-9H2,1-2H3,(H,20,28)/t12-,14?,15+,16+,17-,19-/m0/s1 |
| InChIKey | LIIPIXRTDCEHMK-QAGLHZGHSA-N |
| Mol Weight | 426.42 g/mol |
| Molecular Formula | C19H26N2O9 |
| Exact Mass | 426.16383 g/mol |
| Enantiomer InChIKey | LIIPIXRTDCEHMK-IMEONVBVSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | D2O |
1-(BETA-D-RIBOFURANOSYL)-5-METHYL-3-(4-BROMOPHENYL)-2-THIOXOIMIDAZOLIDIN-4-ONE
ISOARAGOSIDE
N-ACETYL-N-PROP-2-YNYL-2,3,4,6-TETRA-O-ACETYL-ALPHA-D-MANNOPYRANOSYLAMINE
3,6-Epoxy-2H,8H-pyrimido[6,1-b][1,3]oxazocine-8,10(9H)-dione, 3,4,5,6-tetrahydro-4,5-dihydroxy-9-methyl-, [3R-(3.alpha.,4.beta.,5.beta.,6.alpha.)]-
N-(beta-D-glucopyranosyl)thiosalicylamide, pentaacetate
N(ALPHA)-(L-N-ACETYLALANYL)-N(GAMMA)-(2,3,4,6-TETRA-O-ACETYL-ALPHA-D-GALACTOPYRANOSYL)-L-ASPARAGYL-L-ALANINE
1-(3,5-DI-O-BENZOYL-BETA-L-XYLOFURANOSYL)-5-TRIFLUOROMETHYL-URACIL
7-O-BENZYL-MORRONISIDE
PREMNAFOLIOSIDE;3-HYDROXY-4-METHOXYPHENETHYLOXY-BETA-D-(3'-O-ALPHA-L-RHAMNOPYRANOSYL-4'-O-BETA-D-GLUCOPYRANOSYL-6'-O-FERULOYL)-GLUCOPYRANOSIDE
HO-D-HPLA-D-PHE(4-F)-L-CHOI-L-ARGOL
| Title | Journal or Book | Year |
|---|---|---|
| Development of Carbohydrate-Based Scaffolds for Restricted Presentation of Recognition Groups. Extension to Divalent Ligands and Implications for the Structure of Dimerized Receptors | The Journal of Organic Chemistry | 2003 |